157 related articles for article (PubMed ID: 15629776)
1. IL-15-independent antiviral function of primary and memory CD8+ T cells.
Zuo J; Stohlman SA; Bergmann CC
Virology; 2005 Jan; 331(2):338-48. PubMed ID: 15629776
[TBL] [Abstract][Full Text] [Related]
2. Maintenance of CD8(+) T-cell memory following infection with recombinant sindbis and vaccinia viruses.
Villacres MC; Zuo J; Bergmann CC
Virology; 2000 Apr; 270(1):54-64. PubMed ID: 10772979
[TBL] [Abstract][Full Text] [Related]
3. Recombinant vaccinia virus-induced T-cell immunity: quantitation of the response to the virus vector and the foreign epitope.
Harrington LE; Most Rv Rv; Whitton JL; Ahmed R
J Virol; 2002 Apr; 76(7):3329-37. PubMed ID: 11884558
[TBL] [Abstract][Full Text] [Related]
4. Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain.
Mikkelsen M; Holst PJ; Bukh J; Thomsen AR; Christensen JP
J Immunol; 2011 Feb; 186(4):2355-64. PubMed ID: 21257961
[TBL] [Abstract][Full Text] [Related]
5. IL-12 delivery from recombinant vaccinia virus attenuates the vector and enhances the cellular immune response against HIV-1 Env in a dose-dependent manner.
Gherardi MM; Ramirez JC; Rodríguez D; Rodríguez JR; Sano G; Zavala F; Esteban M
J Immunol; 1999 Jun; 162(11):6724-33. PubMed ID: 10352291
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of human T cells by an influenza A vector expressing a CTL epitope from the HER-2/neu protooncogene results in higher numbers of antigen-specific TCRhi cells than stimulation with peptide. Divergent roles of IL-2 and IL-15.
Efferson CL; Kawano K; Tsuda N; Palese P; García-Sastre A; Ioannides CG
Anticancer Res; 2005; 25(2A):715-24. PubMed ID: 15868901
[TBL] [Abstract][Full Text] [Related]
7. Prime-boost vaccinations using recombinant flavivirus replicon and vaccinia virus vaccines: an ELISPOT analysis.
Rattanasena P; Anraku I; Gardner J; Le TT; Wang XJ; Khromykh AA; Suhrbier A
Immunol Cell Biol; 2011 Mar; 89(3):426-36. PubMed ID: 20680025
[TBL] [Abstract][Full Text] [Related]
8. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
[TBL] [Abstract][Full Text] [Related]
9. Sindbis viral vectors transiently deliver tumor-associated antigens to lymph nodes and elicit diversified antitumor CD8+ T-cell immunity.
Granot T; Yamanashi Y; Meruelo D
Mol Ther; 2014 Jan; 22(1):112-22. PubMed ID: 24025748
[TBL] [Abstract][Full Text] [Related]
10. Optimizing vaccine-induced CD8(+) T-cell immunity: focus on recombinant adenovirus vectors.
Bassett JD; Swift SL; Bramson JL
Expert Rev Vaccines; 2011 Sep; 10(9):1307-19. PubMed ID: 21919620
[TBL] [Abstract][Full Text] [Related]
11. Qualitative differences in cellular immunogenicity elicited by hepatitis C virus T-Cell vaccines employing prime-boost regimens.
Tan WG; Zubkova I; Kachko A; Wells F; Adler H; Sutter G; Major ME
PLoS One; 2017; 12(7):e0181578. PubMed ID: 28732046
[TBL] [Abstract][Full Text] [Related]
12. Direct priming and cross-priming contribute differentially to the induction of CD8+ CTL following exposure to vaccinia virus via different routes.
Shen X; Wong SB; Buck CB; Zhang J; Siliciano RF
J Immunol; 2002 Oct; 169(8):4222-9. PubMed ID: 12370352
[TBL] [Abstract][Full Text] [Related]
13. Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responses.
Feder-Mengus C; Schultz-Thater E; Oertli D; Marti WR; Heberer M; Spagnoli GC; Zajac P
Hum Gene Ther; 2005 Mar; 16(3):348-60. PubMed ID: 15812230
[TBL] [Abstract][Full Text] [Related]
14. Cutting edge: requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells.
Schluns KS; Williams K; Ma A; Zheng XX; Lefrançois L
J Immunol; 2002 May; 168(10):4827-31. PubMed ID: 11994430
[TBL] [Abstract][Full Text] [Related]
15. IL-15 transpresentation augments CD8+ T cell activation and is required for optimal recall responses by central memory CD8+ T cells.
Kokaji AI; Hockley DL; Kane KP
J Immunol; 2008 Apr; 180(7):4391-401. PubMed ID: 18354159
[TBL] [Abstract][Full Text] [Related]
16. IL-10 mediates suppression of the CD8 T cell IFN-gamma response to a novel viral epitope in a primed host.
Liu XS; Xu Y; Hardy L; Khammanivong V; Zhao W; Fernando GJ; Leggatt GR; Frazer IH
J Immunol; 2003 Nov; 171(9):4765-72. PubMed ID: 14568953
[TBL] [Abstract][Full Text] [Related]
17. Virological and preclinical characterization of a dendritic cell targeting, integration-deficient lentiviral vector for cancer immunotherapy.
Odegard JM; Kelley-Clarke B; Tareen SU; Campbell DJ; Flynn PA; Nicolai CJ; Slough MM; Vin CD; McGowan PJ; Nelson LT; Ter Meulen J; Dubensky TW; Robbins SH
J Immunother; 2015; 38(2):41-53. PubMed ID: 25658613
[TBL] [Abstract][Full Text] [Related]
18. Evaluating vaccinia virus cytokine co-expression in TLR GKO mice.
Sutherland DB; Ranasinghe C; Regner M; Phipps S; Matthaei KI; Day SL; Ramshaw IA
Immunol Cell Biol; 2011 Aug; 89(6):706-15. PubMed ID: 21173782
[TBL] [Abstract][Full Text] [Related]
19. Trafficking of antigen-specific CD8+ T lymphocytes to mucosal surfaces following intramuscular vaccination.
Kaufman DR; Liu J; Carville A; Mansfield KG; Havenga MJ; Goudsmit J; Barouch DH
J Immunol; 2008 Sep; 181(6):4188-98. PubMed ID: 18768876
[TBL] [Abstract][Full Text] [Related]
20. Actively induced antigen-specific CD8+ T cells by epitope-bearing parasite pre-infection but not prime/boost virus vector vaccination could ameliorate the course of Plasmodium yoelii blood-stage infection.
Ono T; Yamaguchi Y; Oguma T; Takayama E; Takashima Y; Tadakuma T; Miyahira Y
Vaccine; 2012 Sep; 30(44):6270-8. PubMed ID: 22902783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
